Psychosis Early Detection and Intervention Centre-PEDIC, Centre for Psychosocial Medicine, Department for Psychiatry and Psychotherapy, University Medical Centre Hamburg-Eppendorf, Germany.
Schizophr Res. 2012 Sep;140(1-3):31-6. doi: 10.1016/j.schres.2012.07.010. Epub 2012 Jul 28.
This study aims to differentiate schizoaffective disorder (SAD) and bipolar-I-disorder (BD) in first-episode psychotic mania (FEPM).
All 134 patients from an epidemiological first-episode psychosis cohort (N=786) with FEPM and an 18-month follow-up final diagnosis of SAD (n=36) or BD (n=98) were assessed with respect to pre-treatment, baseline and outcome differences. Second, patients with baseline BD who shifted (shifted BD) or did not shift to SAD (stable BD) over the follow-up period were compared regarding pre-treatment and baseline differences.
SAD patients displayed a significantly longer duration of untreated psychosis (DUP; effect size r=0.35), a higher illness-severity at baseline (r=0.20) and more traumatic events (Cramer-V=0.19). SAD patients displayed a significantly higher non-adherence rate (Cramer-V=0.19); controlling for time in treatment and respective baseline scores, SAD patients had significantly worse illness severity (CGI-S; partial η²=0.12) and psychosocial functioning (GAF; partial η(2)=0.07) at 18-months, while BD patients were more likely to achieve remission of positive symptoms (OR=4.9, 95% CI=1.8-13.3; p=0.002) and to be employed/occupied (OR=7.7, 95% CI=2.4-24.4, p=0.001). The main discriminator of stable and shifted BD was a longer DUP in patients shifting from BD to SAD.
It is difficult to distinguish BD with psychotic symptoms and SAD in patients presenting with FEPM. Longer DUP is related to SAD and to a shift from BD to SAD. Compared to BD, SAD had worse outcomes and higher rates of non-adherence with medication. Despite these differences, both diagnostic groups need careful dimensional assessment and monitoring of symptoms and functioning in order to choose the right treatment.
本研究旨在区分首发精神病性躁狂(FEPM)中的分裂情感性障碍(SAD)和双相 I 型障碍(BD)。
对来自流行病学首发精神病队列的 134 名 FEPM 患者(N=786)进行评估,这些患者在 18 个月的随访中有 SAD(n=36)或 BD(n=98)的最终诊断,并评估其治疗前、基线和结局的差异。其次,比较随访期间从 BD 转变为 SAD(转变 BD)或未转变为 SAD(稳定 BD)的基线 BD 患者的治疗前和基线差异。
SAD 患者的未治疗精神病期(DUP;效应大小 r=0.35)明显较长,基线时疾病严重程度更高(r=0.20),创伤事件更多(Cramer-V=0.19)。SAD 患者的不依从率明显较高(Cramer-V=0.19);在控制治疗时间和各自的基线评分后,SAD 患者在 18 个月时的疾病严重程度(CGI-S;部分 η²=0.12)和心理社会功能(GAF;部分 η²=0.07)明显更差,而 BD 患者更有可能缓解阳性症状(OR=4.9,95%CI=1.8-13.3;p=0.002)和就业/在职(OR=7.7,95%CI=2.4-24.4,p=0.001)。稳定 BD 和转变 BD 的主要鉴别因素是从 BD 转变为 SAD 的患者 DUP 较长。
在出现 FEPM 的患者中,BD 伴精神病性症状与 SAD 难以区分。较长的 DUP 与 SAD 以及从 BD 向 SAD 的转变有关。与 BD 相比,SAD 的结局较差,药物依从性较高。尽管存在这些差异,但两个诊断组都需要进行详细的维度评估和症状及功能监测,以便选择正确的治疗方法。